Kendra D. Tutsch
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 10%
- Pathology and Forensic Medicine top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- Dona AlbertiGeorge WildingRhoda ArzoomanianRebecca MarnochaHoward H. BaileyMarcia PomplunChris FeierabendJames P. Thomas
- Topics
- Cancer Treatment and Pharmacology (17 papers)Polyamine Metabolism and Applications (5 papers)Chemotherapy-induced organ toxicity mitigation (5 papers)
- Partner nations
- United StatesSpainGermany
In The Last Decade
Kendra D. Tutsch
39 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 102
- Molecular Biology 773
- Oncology 502
- Cancer Research 207
- Pathology and Forensic Medicine 205
- Pulmonary and Respiratory Medicine 182
Countries citing papers authored by Kendra D. Tutsch
This map shows the geographic impact of Kendra D. Tutsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kendra D. Tutsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kendra D. Tutsch more than expected).
Fields of papers citing papers by Kendra D. Tutsch
This network shows the impact of papers produced by Kendra D. Tutsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kendra D. Tutsch. The network helps show where Kendra D. Tutsch may publish in the future.
Co-authorship network of co-authors of Kendra D. Tutsch
This figure shows the co-authorship network connecting the top 25 collaborators of Kendra D. Tutsch. A scholar is included among the top collaborators of Kendra D. Tutsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kendra D. Tutsch. Kendra D. Tutsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 31 | |
| 2 | 52 | |
| 3 | 11 | |
| 4 | 21 | |
| 5 | 45 | |
| 6 | 100 | |
| 7 | Phase I clinical and pharmacokinetic study of oral penclomedine (NSC 338720) in adults with advanced solid malignancy. | 2 |
| 8 | 16 | |
| 9 | Phase I chemoprevention study of difluoromethylornithine in subjects with organ transplants. | 23 |
| 10 | Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. | 130 |
| 11 | 23 | |
| 12 | Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine. | 37 |
| 13 | 2 | |
| 14 | 9 | |
| 15 | 4 | |
| 16 | 7 | |
| 17 | 2 | |
| 18 | 11 | |
| 19 | 9 | |
| 20 | Improvement in the therapeutic index of cisplatin (NSC 119875) by pharmacologically induced chloruresis in the rat. | 58 |
About Kendra D. Tutsch
Kendra D. Tutsch is a scholar working on Oncology, Biochemistry and Pharmacology, having authored 39 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (17 papers), Polyamine Metabolism and Applications (5 papers) and Chemotherapy-induced organ toxicity mitigation (5 papers). The work is most often cited by research in Oncology (502 citations), Cancer Research (207 citations) and Pathology and Forensic Medicine (205 citations). Kendra D. Tutsch has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Dona Alberti, George Wilding, Rhoda Arzoomanian, Rebecca Marnocha, Howard H. Bailey, Marcia Pomplun, Chris Feierabend, James P. Thomas, Kim Binger and Robert H. Earhart. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.